Previous Article | Next Article 
Infect Immun, June 1998, p. 2619-2624, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Conformational Dependence of
Anaplasma marginale Major Surface Protein 5 Surface-Exposed B-Cell Epitopes
Devere
Munodzana,1,2,
Terry F.
McElwain,2
Donald P.
Knowles,2,3 and
Guy H.
Palmer2,*
Laboratory Diagnostics and Research Branch,
Central Veterinary Laboratory, Harare,
Zimbabwe1;
Department of Veterinary
Microbiology and Pathology, Washington State University, Pullman,
Washington 99164-70402; and
Animal
Disease Research Unit, USDA Agricultural Research Service, Pullman,
Washington 99164-70303
Received 30 December 1997/Returned for modification 4 March
1998/Accepted 18 March 1998
 |
ABSTRACT |
The Anaplasma marginale outer membrane is
composed of immunogenic major surface proteins (MSPs) linked both
covalently and noncovalently in multimeric complexes (M. C. Vidotto, T. C. McGuire, T. F. McElwain, G. H. Palmer, and D. P. Knowles, Infect. Immun. 62:2940-2946).
Consequently, effective induction of antibody against surface-exposed
MSP epitopes has been postulated to require maintenance of MSP
secondary through quatenary structures. Using MSP5 as a model and the
approach of epitope mapping with recombinant expressed full-length and truncated proteins, we demonstrated that the
immunodominant surface epitope bound by monoclonal antibody
(MAb) ANAF16C1 required disparate amino- and carboxy-terminal regions
of MSP5, indicating the conformational dependence of this epitope. The
required amino-terminal MSP5 region included the cysteines involved in
intramolecular disulfide bonding. The dependence of the immunodominant
epitope on disulfide bonding was confirmed by loss of MAb ANAF16C1
binding to MSP5 following disulfide bond reduction and covalent
modification of the reduced sulfhydryl groups. The recognition of the
MSP5 immunodominant epitope by antibody induced by protective
immunization with A. marginale outer membranes was also
conformationally dependent, as shown by the loss of epitope binding
following serum adsorption with native but not reduced and denatured
A. marginale. Importantly, the antibody response to all
immunodominant MSP5 surface epitopes was restricted to conformationally
dependent epitopes, since the binding of polyclonal anti-MSP5
antibody to the A. marginale surface could be blocked by
adsorption with native but not denatured and reduced MSP5. These
results confirm the importance of the secondary and tertiary structures
of MSP epitopes as immune system targets and support the testing of
immunogens which maintain the required conformation.
 |
INTRODUCTION |
Anaplasma
marginale is an arthropod-borne ehrlichial pathogen of cattle
that invades and replicates in mature erythrocytes (7).
Acute infection is characterized by high levels of rickettsemia (>109 infected erythrocytes/ml) and severe anemia, which
frequently results in abortion or death (5, 7).
Immunity against acute A. marginale rickettsemia is directed
against outer membrane surface proteins, and infectivity can be
neutralized with antibodies against surface exposed epitopes (18,
20, 21). Correspondingly, cattle immunized with A. marginale outer membranes develop significantly lower rickettsemia
following challenge than do adjuvant-immunized controls (20, 22,
27). Sera from these immunized and protected cattle recognize six
major surface proteins (MSPs), and antibody titers against MSP2 and
MSP5 correlate with protection against challenge with the
homologous strain (20, 22, 27). In contrast to
protection induced by immunization with whole outer
membranes or a native MSP1a/MSP1b complex, isolated
recombinant-expressed MSPs, either alone or in combination, fail
to induce comparable protection against rickettsemia (17,
18, 20, 27). Consequently, we have hypothesized that MSP
conformation, as determined by secondary through quatenary structures,
is a critical determinant in the efficacy of experimental
vaccines (13, 20, 30).
The outer membrane is composed of MSPs linked both covalently and
noncovalently in multimeric complexes (30). MSP5 and MSP2 occur in both monomeric intramolecularly disulfide-bonded and multimeric intermolecularly disulfide-bonded forms in the membrane: MSP5 as a dimer and MSP2 as a tetramer (19, 30, 31).
Importantly, both MSP5 and MSP2 bear immunodominant B-cell epitopes
and, in outer membrane-immunized cattle, the antibody titer correlates with protection against challenge with the homologous A. marginale strain (19, 27, 31). Based on our hypothesis,
we would predict that the MSP2 and MSP5 immunodominant surface-exposed
epitopes are conformationally dependent and require disulfide bonding
to maintain epitope conformation. We chose to first test this
prediction with intramolecularly disulfide bonded MSP5. MSP5, in
contrast to the antigenically variable MSP2 (2, 19), is
encoded by a single highly conserved gene and expresses invariant
surface epitopes recognized by outer membrane-immunized as well as
previously infected immune cattle (1, 6, 14). In this paper,
we report the disulfide bond and conformational requirements of defined MSP5 surface-exposed epitopes and the results of testing whether antibody binding to the A. marginale surface requires
maintenance of secondary and tertiary structures.
 |
MATERIALS AND METHODS |
Physical mapping.
ANAF16C1 is an immunoglobulin G1 (IgG1)
monoclonal antibody (MAb) directed against the A. marginale
surface and binds MSP5 in all strains of A. marginale,
A. ovis, and A. centrale tested (1, 6, 12,
14). Escherichia coli transformed with plasmid pAM104A
expresses a full-length MSP5 polypeptide that is bound by MAb ANAF16C1
(31). Full-length and truncated msp5 clones expressed as fusion partners with maltose binding protein (MBP) were
used to identify the MSP5 region bound by MAb ANAF16C1. Briefly, the
entire msp5 open reading frame (nucleotides 118 to 753 based on the numbering of the original clone in pAM104A
[31]) was amplified with forward and reverse primers
incorporating XbaI recognition sites, digested, and ligated
in frame into the XbaI site of the vector pMal-c2
(24). The plasmid encoding the full-length MSP5-MBP fusion
was designated msp5.0, and the expressed protein was
designated MSP5.0. The following truncated msp5 clones were generated by the same strategy with site-specific forward and reverse
primers: msp5.1, a 371-bp clone representing bp 118 to 488;
msp5.2, a 356-bp clone representing bp 390 to 745; and
msp5.3, a 483-bp clone representing bp 118 to 600. The
sequences of all clones were verified by double-strand sequencing by
primer extension with dideoxy chain termination (25).
E. coli XL-1 Blue was transformed with each plasmid, and the
expression of an MSP5-MBP fusion protein of the appropriate size was
confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) of recombinant E. coli lysate and immunoblotting
with detection by rabbit anti-MBP polyclonal antibody (3).
The orientations of the full-length and truncated msp5 constructs and the encoded proteins relative to the predicted conformation of native MSP5 are shown in Fig.
1. Each MSP5-MBP fusion protein was
purified on individual amylose affinity columns following extraction as
soluble proteins from recombinant E. coli (24).
Briefly, 2 × 108 bacteria per ml of rich medium (1%
tryptone, 0.5% yeast extract, 0.5% NaCl, 0.2% glucose), containing
100 µg of ampicillin per ml, was incubated in the same medium with
the addition of 0.3 mM
isopropyl-
-D-thiogalactopyranoside (IPTG) for 2 h
at 37°C to induce fusion protein expression. Bacteria were disrupted
by freezing and rapid thawing followed by sonication. The recombinant expressed proteins were collected in the supernatant and loaded on
amylose columns with a binding capacity of 3 mg of MBP per ml of resin.
The columns were washed and the recombinant fusion proteins were eluted
as previously described (24). Eluted recombinant proteins
were detected by immunoblotting with rabbit anti-MBP polyclonal
antibody and then tested for reactivity with MAb ANAF16C1 by SDS-PAGE
and immunoblotting (3). Antibody binding was detected by
using horseradish peroxidase-labeled goat anti-rabbit IgG (for anti-MBP
antibody) or goat anti-murine IgG (for MAbs) and enhanced chemiluminescence (3). Purified nonfusion MBP, and unrelated MBP fusion protein (MBP-Babesia bovis RAP-1
[26]), and uninfected erythrocytes were used as
negative control antigens. A. marginale-infected erythrocytes and E. coli transformed with plasmid pAM104A
were used as positive antigen controls (31). Normal rabbit
serum and the IgG1 MAb Tryp1E1 were used as negative antibody controls.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Physical map of the recombinant MSP5 proteins relative
to a transmembrane helical protein hydrophobicity-hydrophilicity
profile of native MSP5. The map was generated with the Genetics
Computer Group package from the University of Wisconsin. The
y axis reflects the Goldman-Engelman-Steitz hydrophobicity
scale over a window of 20 residues, and the x axis
represents the amino acid position in MSP5. The proteins expressed by
full-length (msp-5.0) or truncated (msp-5.1,
msp-5.2, and msp-5.3) recombinant clones are
plotted against the same x axis, and the positions of the
two cysteines are indicated by the letter C.
|
|
Conformational sensitivity of MAb ANAF16C1 binding.
Affinity-purified MSP5.0 was incubated, at 10 µg per treatment (in
duplicate), with either 8 M urea, 60 mM dithiothreitol (DTT), or 300 mM
iodoacetamide (IA), or one of the combinations DTT and IA; urea and IA;
or urea, DTT, and IA. The urea and DTT treatments were performed at
56°C for 12 h, and the IA treatment was performed for 1 h
at 25°C (4). An untreated sample was incubated identically
and used as a positive control. Reactivity was determined by
immunoblotting (3) with MAb ANAF16C1 or the negative control
MAb Tryp1E1.
Cattle previously immunized with purified
A. marginale outer
membranes developed high titers of anti-MSP5 antibody and were
shown to be protected against acute rickettsemia upon challenge
(
27,
31). Serum obtained postimmunization but prechallenge
was adsorbed with either denatured and reduced (8 M urea, 60 mM
DTT,
300 mM IA) or untreated, native Norton strain organisms
(
28).
As controls, serum either was left unadsorbed or was
adsorbed
by the identical method with either denatured and reduced
E. coli or untreated
E. coli. Adsorption,
performed at 25°C for 1 h, was
repeated until there was no
reactivity with the adsorbing antigen
preparation as determined by
immunoblotting. Each serum treatment
was then tested for inhibition of
MAb ANAF16C1 binding to recombinant
MSP5.0 by a competitive inhibition
enzyme-linked immunosorbent
assay (ELISA) as described previously
(
1,
6). Briefly, individual
wells in 96-well plates were
coated with 1 µg of amylose-resin-purified
MSP5.0 fusion protein in
100 µl of carbonate-bicarbonate coating
buffer (15 mM
Na
2CO
3, 35 mM NaHCO
3 [pH 9.6]).
The wells were incubated
for 1 h at room temperature with 200 µl
of blocking buffer (250
mM K
2HPO
4, 250 mM
KH
2PO
4, 0.5% fraction V bovine serum albumin,
0.75% glycine, 1% sucrose) and then washed four times with
phosphate-buffered
saline (PBS; pH 7.2). The adsorbed and unadsorbed
test sera were
diluted in PBS-1% BSA, to a final dilution of
1:40,000, the dilution
of unadsorbed serum that resulted in
approximately 70% inhibition
of MAb ANAF16C1 binding to MSP5.0.
Adsorbed, diluted sera were
added to triplicate wells in 100-µl
aliquots, and the wells were
incubated at room temperature for 1 h. The wells were washed four
times with 200 µl of PBS per well and
then incubated for 15 min
at room temperature with horseradish
peroxidase-conjugated MAb
ANAF16C1 as described previously (
1,
6). After four additional
washes with PBS, 50 µl of
0.5-µg/µl
o-phenylenediamine hydrochloride
dihydrochloride in substrate buffer (0.2 M
Na
2HPO
4, 0.1 M citric
acid) was added to each
well. The plates were incubated for 10
min, and the reactions were
terminated with 25 µl of 2 N H
2SO
4.
The
results were expressed as percent inhibition (and standard
deviation)
of MAb ANAF16C1 binding to MSP5.0 (
1,
6).
Conformational dependence of antibody binding to A. marginale MSP5 surface exposed epitopes.
Calves were
obtained at 1 day of age and raised in a tick- and fly-free facility at
the Central Veterinary Laboratory, Harare, Zimbabwe. Before
immunization, sera were shown to be unreactive with A. marginale by immunoblotting against whole-organism lysate (11) and by the competitive inhibition MSP-5.0 ELISA
(1, 6). Five calves were immunized by subcutaneous
inoculation of 50 µg of native MSP5, purified from A. marginale on a MAb ANAF16C1 affinity column as described
previously (31), in saponin adjuvant. The immunization was
repeated three times at 3- to 4-week intervals. Five adjuvant control
calves were given saponin alone by using the identical schedule and
route of inoculation. Sera were obtained 1 month after the last
inoculation, and the anti-MSP5 titer was determined by the competitive
inhibition ELISA. As described in Results, all sera from
MSP5-immunized calves had high titers of anti-MSP5 antibody. Two of
these sera were then adsorbed with amylose resin-purified MSP5.0 or
denatured and reduced (8 M urea, 60 mM DTT, 300 mM IA) purified MSP5.0.
As controls, these sera either were left unadsorbed or were adsorbed,
by using the identical protocol, with either denatured and reduced MBP
or untreated MBP. Adsorptions, performed at 25°C for 1 h, were
repeated until there was no reactivity with the adsorbing antigen
preparation as determined by immunoblotting. Unadsorbed and adsorbed
sera were then tested for binding to native surface exposed MSP5
epitopes by agglutination of purified A. marginale as
previously described (19).
 |
RESULTS |
Physical mapping.
The physical maps of the full-length and
truncated MSP5-MBP fusion proteins expressed in pMal-c2 are shown in
Fig. 1. Each fusion protein was purified on individual amylose affinity
columns and identified by SDS-PAGE and immunoblotting with detection by rabbit polyclonal antibody specific for the MBP fusion partner. Figure
2 shows the binding of anti-MBP antibody
to the expected 65-kDa MSP5.0 fusion protein (lane 1) and to MBP alone
(lane 2). The anti-MBP antibody also reacted with the truncated fusion
proteins MSP5.1, MSP5.2, and MSP5.3 (data not shown) but not with
purified A. marginale (lane 3). There was no binding of
control normal rabbit sera to any of the MSP5-MBP fusion proteins
(MSP5.0 is shown in lane 4), MBP (lane 5), or A. marginale (lane 6).

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of recombinant MSP5.0. Lanes 1 and 4 contain
MSP5.0 fused to MBP and purified on an amylose affinity column; lanes 2 and 5 contain MBP alone; and lanes 3 and 6 contain a lysate of
A. marginale-infected erythrocytes. Lanes 1 to 3 were
reacted with rabbit antiserum against MBP; lanes 4 to 6 were reacted
with the same dilution of normal rabbit serum. The positions of the
MSP5.0-MBP fusion protein and MBP alone are indicated in the left
margin.
|
|
Each recombinant MSP5 fusion protein was then tested for reactivity
with MAb ANAF16C1 or the Tryp1E1-negative control MAb
by
immunoblotting. MSP5.0 was bound by MAb ANAF16C1 (Fig.
3, lanes
2 and 3) but not by an isotype
control MAb, Tryp1E1 (lanes 6 and
7). This indicates that the presence
of the MBP fusion partner
does not alter recognition of the MSP5
epitope by MAb ANAF16C1.
This MAb also bound
A. marginale native MSP5 (lane 4). MAb ANAF16C1
did not react with
the negative control
B. bovis RAP-1-MBP fusion
protein
(lane 1). Of the truncated fusion proteins, only MSP5.3
was bound by
MAb ANAF16C1 (Fig.
4, lane 4). ANAF16C1
did not bind
MSP5.1 (lane 2), MSP5.2 (lane 3), or the negative control
B. bovis RAP-1-MBP fusion protein (lane 1). This
reactivity indicates that
not only is the amino-terminal region
(nucleotides 118 to 390,
encoding the first 91 amino acids
including the conserved cysteine
residues) necessary for ANAF16C1
binding but that also some or
all of the region composed of amino
acids 125 to 161 (encoded
by nucleotides 492 to 600) is also required.
These data, without
further mapping, are consistent with conformational
dependence
of the immunodominant epitope bound by MAb ANAF16C1.
Nonfusion
MSP5 expressed by
E. coli containing
plasmid p104A was used as
a positive control and was bound, as
expected, by MAb ANAF16C1
(Fig.
4, lane 5).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
MAb ANAF16C1 binds recombinant MSP5.0. Lanes 1 and 5 contain B. bovis RAP-1-MBP fusion protein as a negative
antigen control; lanes 2, 3, 6, and 7 contain MSP5.0-MBP fusion protein
(lanes 2 and 6 contain protein from a different column fraction from
the protein in lanes 3 and 7); lanes 4 and 8 contain a lysate of
A. marginale-infected erythrocytes. Lanes 1 to 4 were
reacted with MAb ANAF16C1; lanes 5 to 8 were reacted with the isotype
control MAb Tryp1E1. The positions of the MSP5.0-MBP fusion protein and
the native MSP5 are indicated in the left margin.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
MAb ANAF16C1 binds recombinant MSP5.3 but not MSP5.1 or
MSP5.2. Lanes 1 and 6 contain B. bovis RAP-1-MBP fusion
protein as a negative antigen control; lanes 2 and 7 contain MSP5.1-MBP
fusion protein; lanes 3 and 8 contain MSP5.2-MBP fusion protein; lanes
4 and 9 contain MSP5.3-MBP fusion protein; and lanes 5 and 10 contain nonfusion MSP5 expressed by E. coli containing
plasmid p104A (31). Lanes 1 to 5 were reacted with MAb
ANAF16C1; lanes 6 to 10 were reacted with the isotype control MAb
Tryp1E1. The positions of the MSP5.3-MBP fusion protein and nonfusion
MSP5 are indicated in the left margin.
|
|
Conformational sensitivity of MAb ANAF16C1 binding.
The
conformational dependence of MSP5 was tested by treatment of purified
MSP5.0 with denaturing and reducing agents followed by determination of
MAb ANAF16C1 binding. Reduction of disulfide bonds with DTT followed by
covalent modification of sulfhydryl groups with IA to prevent
reoxidation completely abolished MAb binding (Fig.
5). This effect was probably due to the
effect on disulfide bonding, since neither DTT nor IA alone had any
detectable effect on the epitope (Fig. 5). This dependence on
disulfide bonding is consistent with the epitope-mapping results,
which showed a requirement for the amino-terminal half of MSP5,
containing the conserved cysteine residues. Treatment with 8 M urea,
which denatures the protein secondary structure, resulted in a partial
loss of MAb ANAF16C1 binding (Fig. 5). This effect is again consistent with a conformationally dependent epitope and may involve both the
amino- and carboxy-terminal hydrophilic regions.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
MAb ANAF16C1 binding is sensitive to denaturation and
reduction of MSP5. Purified MSP5.0 was either untreated or
treated with 8 M urea (MSP5.0+urea); 60 mM dithiothreitol
(MSP5.0+DTT); DTT and 300 mM IA (MSP5.0+DTT+IA); urea, DTT, and IA
(MSP5.0+urea+DTT+IA); urea and IA (MSP5.0+urea+IA); or IA alone
(MSP5.0+IA). Samples were reacted in duplicate with either MAb ANAF16C1
(left) or the negative control MAb Tryp1E1 (right).
|
|
To test whether recognition of the MSP5 immunodominant epitope by
antibody from outer membrane-immunized and protected cattle
was also
conformationally dependent, serum was adsorbed with native
or
reduced and denatured
A. marginale lysate and then
tested for
the ability to inhibit MAb ANAF16C1 binding.
Unadsorbed serum
was diluted (1:40,000) to achieve 70%
inhibition of MAb ANAF16C1
binding (Table
1). All test samples following adsorption
were
then tested at a final dilution of 1:40,000. As shown in Table
1,
adsorption with native
A. marginale significantly
depleted
bovine serum antibody inhibition of MAb ANAF16C1 binding. In
contrast,
adsorption with native
E. coli or reduced and
denatured
A. marginale or
E. coli did not
significantly reduce the binding of the immune
bovine serum to the MSP5
immunodominant epitope (Table
1). This
indicates that the antibody
response to this MSP5 epitope following
effective outer membrane
immunization is conformationally restricted.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Binding of antibody induced by outer membrane
immunization to the MSP5 immunodominant epitope is dependent on
native conformation of A. marginale
|
|
Conformational dependence of antibody binding to A. marginale MSP5 surface-exposed epitopes.
Immunization of
cattle with native MSP5 induced high titers of antibody against the
immunodominant MSP5 epitope, as determined by the competitive
inhibition ELISA based on ANAF16C1 binding (data not shown). Sera from
two of the MSP5-immunized cattle were then used to determine if
recognition of MSP5 epitopes on the A. marginale
surface was conformationally dependent. Unadsorbed sera had end-point
agglutination titers of 512, while adsorption with native MSP5.0
diminished surface binding 32- and 64-fold, respectively, for each of
the two test sera (Table 2). In contrast, adsorption with denatured and reduced MSP5.0 lysate either did not alter (anti-MSP5.0 serum 1) or only slightly diminished
(anti-MSP5.0 serum 2) surface reactivity compared to negative control
adsorptions with either native or reduced and denatured MBP (Table 2).
Sera from the five cattle immunized with saponin alone had end-point agglutination titers of 4 or less (data not shown). These results indicate that the antibody response to MSP5, as presented on the A. marginale surface, is predominantly against
conformationally dependent epitopes.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Binding of anti-MSP5 sera to the A. marginale surface requires reactivity with native,
nondenatured epitopes
|
|
 |
DISCUSSION |
Why individual MSPs fail to induce protection at a level
comparable to that induced by immunization with intact A. marginale outer membranes is unknown and represents an important
gap in our knowledge needed to develop and improve vaccines against
ehrlichial pathogens. Possible explanations, which are not mutually
exclusive, include the following: (i) each MSP alone induces partially
protective immunity, and the efficacy of the outer membrane complex
simply reflects the sum of the individual components; (ii) the
multimeric outer membrane complex enhances antigen presentation
compared to soluble individual MSPs and generates a phenotypically
different immune response; and (iii) induction of protection requires
antibody to conformationally dependent epitopes on the
A. marginale surface. The first possibility is not
congruent with data showing that combinations of up to three MSPs do
not consistently enhance protection compared to that afforded by
immunization with individual MSPs (17, 18, 20, 23). In
contrast, both the second and third explanations remain viable. As an
entrée to investigating the importance of antibody against
conformationally dependent epitopes, we analyzed the structural
requirements of a highly conserved immunodominant epitope on MSP5.
This epitope, defined by binding of MAb ANAF16C1, is conserved
among all tested strains of A. marginale, A. centrale, and A. ovis and induces high titers of
antibody in all infected species including cattle, sheep, and goats
(1, 6, 14, 31). Initial physical mapping of the epitope
with full-length and truncated recombinant expressed MSP5 indicated that residues encoded 5' to nucleotide 390 (amino acid 91) as well as
some or all of the region encoded by nucleotides 492 to 600 (amino
acids 125 to 161) were required. Importantly, the required amino-terminal region included the conserved cysteines (31), consistent with the proposed importance of intramolecular disulfide bonding in the MSP conformation (30). The absolute
dependence of the immunodominant epitope on disulfide bonding was
confirmed by the loss of MAb ANAF16C1 binding to MSP5.0 following
disulfide bond reduction and covalent modification of the reduced
sulfhydryl groups. Interestingly, MAb binding was also reduced after
urea treatment alone (Fig. 5). This suggests that secondary protein structure, apart from the tertiary requirements for intramolecular disulfide bonding, is also needed for epitope conformation, a finding consistent with the physical mapping results indicating contributions from two distant hydrophilic regions of MSP5. Whether amino acids in these disparate regions are juxtaposed to form the
actual epitope (defined by binding to the complementarity determining regions of the antibody) or whether the epitope is encoded within one of the regions and the second is required only to
provide correct secondary structure for binding is unknown. Both
scenarios are consistent with the requirement for disulfide bonding in
or adjacent to a hydrophobic segment interposed between two hydrophilic
and presumed surface-exposed regions of MSP5 (Fig. 1).
The single MSP5 epitope defined by MAb ANAF16C1 binding was
analyzed as a model for immunodominant MSP epitopes (11, 20, 30). The presence of conserved cysteines and disulfide bonds in
MSP2 and MSP4 (15, 19, 30) suggests that conformational dependence may be a common feature among A. marginale
MSPs. In addition, the presence of an MSP5 homolog in Cowdria
ruminantium MAP-2 (8) and of MSP2 homologs in
C. ruminantium MAP1 (19, 29) and Ehrlichia
chaffeenesis OMP-1 (16) provides support for broad
applicability of this model among ehrlichial pathogens.
Importantly, antibodies induced by outer membrane immunization, which
results in high anti-MSP5 antibody titers that correlate with
protection against homologous challenge (27), recognized the
MSP5 immunodominant epitope in a conformationally dependent form,
as shown by the results in Table 1. Furthermore, the polyclonal antibody induced by native MSP5 immunization also recognized
predominantly conformationally dependent epitopes on the
A. marginale surface. This indicates that the surface
binding of antibody to all MSP5 immunodominant epitopes is
conformationally dependent and is consistent with a requirement for
native-protein secondary and tertiary structures in effective
immunization.
In contrast to the secondary- and tertiary-structure requirements
for MSP5 B-cell epitopes, the role of the quatenary structure remains unclear. Membrane MSP5 and MSP2 occur as both intramolecularly disulfide bonded monomers and intermolecularly disulfide linked multimers. Although monomeric MSPs, including MSP2 and MSP5, induce antibody against the A. marginale surface, complete
neutralization of infectivity may require antibody directed against
functional surface regions composed of two or more MSPs (13,
30). This possibility is suggested by the greater inhibition of
A. marginale binding to the erythrocyte surface by
antibodies generated against native organisms or a complex of MSP1a and
MSP1b compared to antibody generated against MSP1a and MSP1b
individually (9, 10). The importance of antibody against
multiple MSPs is also supported by the complete neutralization of in
vivo infectivity by antibody generated against the intact outer
membranes (21). Whether intermolecular bonding of
MSPs results in different B-cell epitopes from those resulting from
intramolecularly bonded MSPs is unknown, although the high degree of
conformational dependence shown in the present study suggests that
changes in bonding pattern are likely to alter the surface-exposed
epitopes. Consequently, defining the structural requirements of
critical outer membrane epitopes is a priority and will support the
development and testing of vaccines that maintain native MSP
structure. These approaches include recombinant MSP immune
system-stimulating complexes, expression of multiple recombinant
MSPs in the outer membranes of live bacterial vectors, and
direct immunization with DNA encoding MSPs.
 |
ACKNOWLEDGMENTS |
This work was supported by U.S. Agency for International
Development grant 263-0152-A-00-2207-00, The Central Veterinary
Laboratory of Zimbabwe, U.S. Department of Agriculture National
Research Initiative Competitive Grants Program grant 95-37204-2348, and USDA-BARD grant US-2238-92C.
We acknowledge Beverly Hunter, Carla Robertson, and Will Harwood for
technical assistance and Unesu Ushewokunze-Obatolu for her continuous
support of this project and of D.M.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Microbiology and Pathology, Washington State University,
Pullman, WA 99164-7040. Phone: (509) 335-6033. Fax: (509) 335-8328. E-mail: gpalmer{at}vetmed.wsu.edu.
This paper is dedicated to the memory of Devere Munodzana and to
his family.
Deceased.
Editor: P. E. Orndorff
 |
REFERENCES |
| 1.
|
Echaide, S. T.,
D. P. Knowles,
T. C. McGuire,
G. H. Palmer,
C. E. Suarez, and T. F. McElwain.
1998.
Detection of cattle naturally infected with Anaplasma marginale in an endemic region using nested PCR and recombinant MSP5-cELISA.
J. Clin. Microbiol.
36:777-782[Abstract/Free Full Text].
|
| 2.
|
Eid, G.,
D. M. French,
A. Lundgren,
A. F. Barbet,
T. F. McElwain, and G. H. Palmer.
1996.
Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia.
Infect. Immun.
64:836-841[Abstract].
|
| 3.
|
Gallagher, S.,
S. E. Winston,
S. A. Fuller, and J. G. R. Hurrell.
1993.
Immunoblotting and Immunodetection, p. 10.8.1-10.8.17.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, Inc., New York.
|
| 4.
|
Hotzel, I.,
W. C. Brown,
T. F. McElwain,
S. D. Rodriguez, and G. H. Palmer.
1996.
Dimorphic sequences of rap-1 genes encode B and CD4+ T helper lymphocyte epitopes in the Babesia bigemina rhoptry associated protein-1 (RAP-1).
Mol. Biochem. Prasitol.
81:89-99.
|
| 5.
|
Kieser, S. T.,
I. S. Eriks, and G. H. Palmer.
1990.
Cyclic rickettsemia during persistent Anaplasma marginale infection of cattle.
Infect. Immun.
58:1117-1119[Abstract/Free Full Text].
|
| 6.
|
Knowles, D. P.,
S. Torioni de Echaide,
G. H. Palmer,
T. C. McGuire,
D. Stiller, and T. F. McElwain.
1996.
Antibody against an Anaplasma marginale MSP-5 epitope common to tick and erythrocyte stages identifies persistently infected cattle.
J. Clin. Microbiol.
34:2225-2230[Abstract].
|
| 7.
|
Losos, G. J.
1986.
Anaplasmosis, p. 742-795.
In
G. J. Losos (ed.), Infectious tropical diseases of domestic animals. Longman Press, Harlow, United Kingdom.
|
| 8.
|
Mahan, S. M.,
T. C. McGuire,
S. M. Semu,
M. V. Bowie,
F. Jongejan,
F. R. Rurangirwa, and A. F. Barbet.
1994.
Molecular cloning of a gene encoding the immunogenic 21-kDa protein of Cowdria ruminantium.
Microbiology
140:2135-2142[Abstract/Free Full Text].
|
| 9.
|
McGarey, D. J., and D. R. Allred.
1994.
Characterization of hemagglutinating components of the Anaplasma marginale initial body surface and identification of possible adhesins.
Infect. Immun.
62:4587-4593[Abstract/Free Full Text].
|
| 10.
|
McGarey, D. J.,
A. F. Barbet,
G. H. Palmer,
T. C. McGuire, and D. R. Allred.
1994.
Putative adhesins of Anaplasma marginale major surface polypeptides (MSP) 1a and 1b.
Infect. Immun.
62:4594-4601[Abstract/Free Full Text].
|
| 11.
|
McGuire, T. C.,
W. C. Davis,
A. L. Brassfield,
T. F. McElwain, and G. H. Palmer.
1991.
Identification of Anaplasma marginale long-term carrier cattle by detection of serum antibody to isolated MSP-3.
J. Clin. Microbiol.
29:788-793[Abstract/Free Full Text].
|
| 12.
|
McGuire, T. C.,
G. H. Palmer,
W. L. Goff,
M. I. Johnson, and W. C. Davis.
1984.
Common and isolate restricted antigens of Anaplasma marginale detected with monoclonal antibodies.
Infect. Immun.
45:697-700[Abstract/Free Full Text].
|
| 13.
|
Musoke, A. J.,
G. H. Palmer,
T. F. McElwain,
V. Nene, and D. McKeever.
1996.
Prospects for subunit vaccines against tick-borne diseases.
Br. Vet. J.
152:621-639[Medline].
|
| 14.
|
Ndung'u, L. W.,
C. Aguirre,
R. R. Rurangirwa,
T. F. McElwain,
T. C. McGuire,
D. P. Knowles, and G. H. Palmer.
1995.
Detection of Anaplasma ovis infection in goats using the MSP5 competitive inhibition ELISA.
J. Clin. Microbiol.
33:675-679[Abstract].
|
| 15.
|
Oberle, S. M., and A. F. Barbet.
1993.
Derivation of the complete msp-4 gene sequence of Anaplasma marginale without cloning.
Gene
136:291-294[Medline].
|
| 16.
|
Ohashi, N.,
N. Zhi,
Y. Zhang, and Y. Rikihisa.
1998.
Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family.
Infect. Immun.
66:132-139[Abstract/Free Full Text].
|
| 17.
|
Palmer, G. H.,
A. F. Barbet,
G. H. Cantor, and T. C. McGuire.
1989.
Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate.
Infect. Immun.
57:3666-3669[Abstract/Free Full Text].
|
| 18.
|
Palmer, G. H.,
A. F. Barbet,
W. C. Davis, and T. C. McGuire.
1986.
Immunization with an isolate-common surface protein protects cattle against anaplasmosis.
Science
231:1299-1302[Abstract/Free Full Text].
|
| 19.
|
Palmer, G. H.,
G. Eid,
A. F. Barbet,
T. C. McGuire, and T. F. McElwain.
1994.
The immunoprotective Anaplasma marginale major surface protein-2 (MSP-2) is encoded by a polymorphic multigene family.
Infect. Immun.
62:3808-3816[Abstract/Free Full Text].
|
| 20.
|
Palmer, G. H., and T. F. McElwain.
1995.
Molecular basis for vaccine development against anaplasmosis and babesiosis.
Vet. Parasitol.
57:233-253[Medline].
|
| 21.
|
Palmer, G. H., and T. C. McGuire.
1984.
Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle.
J. Immunol.
133:1010-1015[Abstract].
|
| 22.
|
Palmer, G. H.,
D. Munodzana,
N. Tebele,
T. Ushe, and T. F. McElwain.
1994.
Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes.
Vet. Immunol. Immunopathol.
42:265-273[Medline].
|
| 23.
|
Palmer, G. H.,
S. M. Oberle,
A. F. Barbet,
W. C. Davis,
W. L. Goff, and T. C. McGuire.
1988.
Immunization with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge.
Infect. Immun.
56:1526-1531[Abstract/Free Full Text].
|
| 24.
|
Riggs, P.
1994.
Expression and purification of maltose-binding protein fusions, p. 16.6.1-16.6.14.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, Inc., New York, N.Y.
|
| 25.
|
Slatko, B. E.,
L. M. Albright, and S. Tabor.
1994.
DNA sequencing by the dideoxy method, p. 7.4.1-7.4.35.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. John Wiley & Sons, Inc., New York, N.Y.
|
| 26.
|
Suarez, C. E.,
G. H. Palmer,
D. P. Jasmer,
S. A. Hines,
L. E. Perryman, and T. F. McElwain.
1991.
Characterization of the gene encoding a 60kD Babesia bovis merozoite protein with conserved and surface exposed epitopes.
Mol. Biochem. Parasitol.
46:45-52[Medline].
|
| 27.
|
Tebele, N.,
T. C. McGuire, and G. H. Palmer.
1991.
Induction of protective immunity using Anaplasma marginale initial body membranes.
Infect. Immun.
59:3199-3204[Abstract/Free Full Text].
|
| 28.
|
Tebele, N., and G. H. Palmer.
1991.
Crossprotective immunity between the Florida and a Zimbabwe stock of Anaplasma marginale.
Trop. Anim. Health Prod.
23:197-202[Medline].
|
| 29.
|
Van Vliet, A. H. M.,
F. Jongejan,
M. Van Kleef, and B. A. M. Van Der Zeist.
1994.
Molecular cloning, sequence analysis, and expression of the gene encoding the immunodominant 32-kilodalton protein of Cowdria ruminantium.
Infect. Immun.
62:1451-1456[Abstract/Free Full Text].
|
| 30.
|
Vidotto, M.,
T. C. McGuire,
T. F. McElwain,
G. H. Palmer, and D. P. Knowles.
1994.
Intermolecular relationships of major surface proteins of Anaplasma marginale.
Infect. Immun.
62:2940-2946[Abstract/Free Full Text].
|
| 31.
|
Visser, E. S.,
T. C. McGuire,
G. H. Palmer,
W. C. Davis,
V. Shkap,
E. Pipano, and D. P. Knowles.
1992.
The Anaplasma marginale msp5 gene encodes a 19-kilodalton protein conserved in all recognized Anaplasma species.
Infect. Immun.
60:5139-5144[Abstract/Free Full Text].
|
Infect Immun, June 1998, p. 2619-2624, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Luo, T., Zhang, X., Wakeel, A., Popov, V. L., McBride, J. W.
(2008). A Variable-Length PCR Target Protein of Ehrlichia chaffeensis Contains Major Species-Specific Antibody Epitopes in Acidic Serine-Rich Tandem Repeats. Infect. Immun.
76: 1572-1580
[Abstract]
[Full Text]
-
Nethery, K. A., Doyle, C. K., Zhang, X., McBride, J. W.
(2007). Ehrlichia canis gp200 Contains Dominant Species-Specific Antibody Epitopes in Terminal Acidic Domains. Infect. Immun.
75: 4900-4908
[Abstract]
[Full Text]
-
Dreher, U. M., de la Fuente, J., Hofmann-Lehmann, R., Meli, M. L., Pusterla, N., Kocan, K. M., Woldehiwet, Z., Braun, U., Regula, G., Staerk, K. D. C., Lutz, H.
(2005). Serologic Cross-Reactivity between Anaplasma marginale and Anaplasma phagocytophilum. CVI
12: 1177-1183
[Abstract]
[Full Text]
-
Kocan, K. M., de la Fuente, J., Guglielmone, A. A., Melendez, R. D.
(2003). Antigens and Alternatives for Control of Anaplasma marginale Infection in Cattle. Clin. Microbiol. Rev.
16: 698-712
[Abstract]
[Full Text]
-
McBride, J. W., Corstvet, R. E., Gaunt, S. D., Boudreaux, C., Guedry, T., Walker, D. H.
(2003). Kinetics of Antibody Response to Ehrlichia canis Immunoreactive Proteins. Infect. Immun.
71: 2516-2524
[Abstract]
[Full Text]
-
Alleman, A. R., McSherry, L. J., Barbet, A. F., Breitschwerdt, E. B., Sorenson, H. L., Bowie, M. V., Belanger, M.
(2001). Recombinant Major Antigenic Protein 2 of Ehrlichia canis: a Potential Diagnostic Tool. J. Clin. Microbiol.
39: 2494-2499
[Abstract]
[Full Text]
-
Alleman, A. R., Barbet, A. F., Bowie, M. V., Sorenson, H. L., Wong, S. J., Bélanger, M.
(2000). Expression of a Gene Encoding the Major Antigenic Protein 2 Homolog of Ehrlichia chaffeensis and Potential Application for Serodiagnosis. J. Clin. Microbiol.
38: 3705-3709
[Abstract]
[Full Text]
-
Exner, M. M., Wu, X., Blanco, D. R., Miller, J. N., Lovett, M. A.
(2000). Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes. Infect. Immun.
68: 2647-2654
[Abstract]
[Full Text]
-
Camacho-Nuez, M., de Lourdes Munoz, M., Suarez, C. E., McGuire, T. C., Brown, W. C., Palmer, G. H.
(2000). Expression of Polymorphic msp1beta Genes during Acute Anaplasma marginale Rickettsemia. Infect. Immun.
68: 1946-1952
[Abstract]
[Full Text]
-
Palmer, G. H., Abbott, J. R., French, D. M., McElwain, T. F.
(1998). Persistence of Anaplasma ovis Infection and Conservation of the msp-2 and msp-3 Multigene Families within the Genus Anaplasma. Infect. Immun.
66: 6035-6039
[Abstract]
[Full Text]